Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Deletion of the Polycomb-Group Protein EZH2 Leads to Compromised Self-Renewal and Differentiation Defects in Human Embryonic Stem Cells.

Collinson A, Collier AJ, Morgan NP, Sienerth AR, Chandra T, Andrews S, Rugg-Gunn PJ.

Cell Rep. 2016 Dec 6;17(10):2700-2714. doi: 10.1016/j.celrep.2016.11.032.

2.

A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding.

Douthwaite J, Moisan J, Privezentzev C, Soskic B, Sabbah S, Cohen S, Collinson A, England E, Huntington C, Kemp B, Zhuang L, Hudak S, Rees DG, Goldberg D, Barton C, Chang L, Vainshtein I, Liang M, Iciek L, Ambery P, Peakman M, Vaughan TJ, Tree TI, Sansom DM, Bowen MA, Minter RR, Jermutus L.

J Immunol. 2017 Jan 1;198(1):528-537. Epub 2016 Nov 23.

PMID:
27881707
3.

Schedules for Pneumococcal Vaccination of Preterm Infants: An RCT.

Kent A, Ladhani SN, Andrews NJ, Scorrer T, Pollard AJ, Clarke P, Hughes SM, Heal C, Menson E, Chang J, Satodia P, Collinson AC, Faust SN, Goldblatt D, Miller E, Heath PT; PUNS Study Group..

Pediatrics. 2016 Sep;138(3). pii: e20153945. doi: 10.1542/peds.2015-3945. Epub 2016 Aug 8.

PMID:
27503351
4.

Neonatal gram-negative infections, antibiotic susceptibility and clinical outcome: an observational study.

Kent A, Kortsalioudaki C, Monahan IM, Bielicki J, Planche TD, Heath PT, Sharland M; Neonatal Gram Negative MIC group..

Arch Dis Child Fetal Neonatal Ed. 2016 Mar 7. pii: fetalneonatal-2015-309554. doi: 10.1136/archdischild-2015-309554. [Epub ahead of print]

PMID:
26951742
5.

Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age.

Snape MD, Voysey M, Finn A, Bona G, Esposito S, Principi N, Diez-Domingo J, Sokal E, Kieninger D, Prymula R, Dull PM, Kohl I, Barone M, Wang H, Toneatto D, Pollard AJ; European MenB Vaccine Study Group..

Pediatr Infect Dis J. 2016 Apr;35(4):e113-23. doi: 10.1097/INF.0000000000001056.

PMID:
26756390
6.

Outcomes after viral load rebound on first-line antiretroviraltreatment in children with HIV in the UK and Ireland: an observational cohort study.

Childs T, Shingadia D, Goodall R, Doerholt K, Lyall H, Duong T, Judd A, Gibb DM, Collins IJ; CHIPS Steering Committee..

Lancet HIV. 2015 Apr;2(4):e151-8.

7.

Endocrine mucin-producing sweat gland carcinoma of the eyelid.

Collinson AC, Sun MT, James C, Huilgol SC, Selva D.

Int Ophthalmol. 2015 Dec;35(6):883-6. doi: 10.1007/s10792-015-0127-x. Epub 2015 Sep 15.

PMID:
26373656
8.

HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.

Harrison L, Melvin A, Fiscus S, Saidi Y, Nastouli E, Harper L, Compagnucci A, Babiker A, McKinney R, Gibb D, Tudor-Williams G; PENPACT-1 (PENTA 9PACTG 390) Study Team..

J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):42-53. doi: 10.1097/QAI.0000000000000671.

9.

Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.

Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE Jr; PENPACT-1 (PENTA 9/PACTG 390) Study Team..

Pediatrics. 2014 Oct;134(4):e1104-16. doi: 10.1542/peds.2014-0527.

10.

Polygenic in vivo validation of cancer mutations using transposons.

Chew SK, Lu D, Campos LS, Scott KL, Saci A, Wang J, Collinson A, Raine K, Hinton J, Teague JW, Jones D, Menzies A, Butler AP, Gamble J, O'Meara S, McLaren S, Chin L, Liu P, Futreal PA.

Genome Biol. 2014 Sep 27;15(9):455. doi: 10.1186/s13059-014-0455-6.

11.

Characterizing the burden of invasive Pseudomonas infection on neonatal units in the UK between 2005 and 2011.

Kadambari S, Botgros A, Clarke P, Vergnano S, Anthony M, Chang J, Collinson A, Embleton N, Kennea N, Settle P, Heath PT, Menson EN; NeonIN Neonatal Infection Surveillance Network..

J Hosp Infect. 2014 Oct;88(2):109-12. doi: 10.1016/j.jhin.2014.07.006. Epub 2014 Jul 30.

PMID:
25146224
12.

Reply to 'management of mineral metabolism in haemodialysis patients: need for new strategies'.

Collinson A, McMullan M, Sadler H, Tse WY.

Eur J Clin Nutr. 2014 Jul;68(7):861. doi: 10.1038/ejcn.2014.73. Epub 2014 Apr 30. No abstract available.

PMID:
24781686
13.

Managing serum phosphate in haemodialysis patients: time for an innovative approach?

Collinson A, McMullan M, Tse WY, Sadler H.

Eur J Clin Nutr. 2014 Mar;68(3):392-6. doi: 10.1038/ejcn.2013.283. Epub 2014 Jan 15.

PMID:
24424075
14.

How Do medical students respond to emotional cues and concerns expressed by simulated patients during OSCE consultations?--a multilevel study.

Zhou Y, Collinson A, Laidlaw A, Humphris G.

PLoS One. 2013 Oct 23;8(10):e79166. doi: 10.1371/journal.pone.0079166. eCollection 2013.

15.

Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.

White JK, Gerdin AK, Karp NA, Ryder E, Buljan M, Bussell JN, Salisbury J, Clare S, Ingham NJ, Podrini C, Houghton R, Estabel J, Bottomley JR, Melvin DG, Sunter D, Adams NC; Sanger Institute Mouse Genetics Project., Tannahill D, Logan DW, Macarthur DG, Flint J, Mahajan VB, Tsang SH, Smyth I, Watt FM, Skarnes WC, Dougan G, Adams DJ, Ramirez-Solis R, Bradley A, Steel KP.

Cell. 2013 Jul 18;154(2):452-64. doi: 10.1016/j.cell.2013.06.022.

16.

Red meat, dietary heme iron, and risk of type 2 diabetes: the involvement of advanced lipoxidation endproducts.

White DL, Collinson A.

Adv Nutr. 2013 Jul 1;4(4):403-11. doi: 10.3945/an.113.003681. Review.

17.

Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.

Ravn P, Madhurantakam C, Kunze S, Matthews E, Priest C, O'Brien S, Collinson A, Papworth M, Fritsch-Fredin M, Jermutus L, Benthem L, Gruetter M, Jackson RH.

J Biol Chem. 2013 Jul 5;288(27):19760-72. doi: 10.1074/jbc.M112.426288. Epub 2013 May 20.

18.

Lopinavir dosing in HIV-infected children in the United Kingdom and Ireland.

Donegan K, Doerholt K, Judd A, Lyall H, Menson E, Butler K, Tookey P, Riordan A, Shingadia D, Tudor-Williams G, Gibb DM, Walker AS; Collaborative HIV Paediatric Study (CHIPS)..

Pediatr Infect Dis J. 2013 Jan;32(1):45-50. doi: 10.1097/INF.0b013e31827842c9.

PMID:
23076384
19.

Safety in numbers: anaphylaxis risk in childhood immunisation.

Collinson A.

Arch Dis Child. 2012 Jun;97(6):485-6. doi: 10.1136/archdischild-2012-301846. No abstract available.

PMID:
22611111
20.

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.

Gossger N, Snape MD, Yu LM, Finn A, Bona G, Esposito S, Principi N, Diez-Domingo J, Sokal E, Becker B, Kieninger D, Prymula R, Dull P, Ypma E, Toneatto D, Kimura A, Pollard AJ; European MenB Vaccine Study Group..

JAMA. 2012 Feb 8;307(6):573-82. doi: 10.1001/jama.2012.85.

PMID:
22318278

Supplemental Content

Loading ...
Support Center